Digital amputations
Conditions
Interventions
Group 1 is defined by UFH 0 units per day. Pre-observation period is defined as from the first outpatient consultation to completion of surgery. The onset of the study is defined to be the time of re
Sponsors
New Tokyo Hospital
University of Tsukuba Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Patients who have an amputated digit together with abnormal blood flow and seek replantation of the digit. 2)Patients who have undergone intraoperative anastomosis of the vein. 3)Patients who voluntarily give written consent to their participation in this study (or consent by the patient's family) after explanation and understanding of the study.
Exclusion criteria
Exclusion criteria: 1) Patients who decide to withdraw their consent to participate. 2) Patients who have a history of hypersensitivity to UFH component. 3) Patients who have a history of thrombocytopenia caused by heparin. 4) are currently receiving oral administration of anticoagulants or anti-platelet agents. 5) Patients who have a history of blood diseases (such as idiopathic thrombocytopenic purpura.) 6) Patients who have severe hepatic diseases (with AST or ALT levels of 100 U/L or higher). 7) Patients who have severe renal disease (with BUN levels of 25 mg/dL or higher, or serum creatinine levels of 2.0 mg/dL or higher). 8) Patients who are pregnant or lactating.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of the success rate at 2 weeks after replantation of amputated digits | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of the partial success rate, severity of anemia, blood transfusion volume when needed, and presence or absence of infection. | — |
Countries
Japan
Contacts
Public ContactAKIO NISHIJIMA
New Tokyo Hospital Department of Plastic and Reconstructive Surgery
Outcome results
None listed